Your session is about to expire
← Back to Search
Study Summary
This trial is designed to study the independent and combined effects of four components of mindfulness-based behavioral therapy on eating pathology. The four components are Mindful Awareness, Distress Tolerance, Emotion Modulation, and Values-Based Decision Making. The trial will compare the efficacy of each component when used alone and in combination with standard behavioral treatment for bulimia nervosa and binge eating disorder. The primary aim of the study is to evaluate the independent efficacy of each treatment component on eating pathology. Secondary aims are to test the hypotheses that the efficacy of each component is moderated by related baseline deficits in self-regulation, and to quantify the component interaction
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had 12 or more episodes of losing control within the last 3 months.You have had 12 or more episodes of losing control in the past 3 months.I need urgent care for health issues caused by my eating disorder.You weigh more than what is considered healthy for your height.You are not too underweight.You are able to give informed consent.
- Group 1: Base BT
- Group 2: Base BT + Distress Tolerance
- Group 3: Base BT + Emotion Regulation
- Group 4: Base BT + Mindful Awareness
- Group 5: Base BT + Values
- Group 6: Base BT + Distress Tolerance and Emotion Modulation
- Group 7: Base BT + Distress Tolerance and Mindful Awareness
- Group 8: Base BT + Distress Tolerance and Values
- Group 9: Base BT + Emotion Modulation and Mindful Awareness
- Group 10: Base BT + Mindful Awareness and Values
- Group 11: Base BT + Emotion Modulation and Values
- Group 12: Base BT + EM, DT, MA
- Group 13: Base BT + DT, ER, and V
- Group 14: Base BT + DT, MA, and V
- Group 15: Base BT + ER, MA, and V
- Group 16: Base BT + ER, MA, V, DT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do I satisfy the criteria to join this investigation?
"Prospective participants in this clinical trial should have been diagnosed with bulimia nervosa and must be between 18 to 70 years old. A total of 300 individuals will be selected for the trialling period."
Is this medical trial entertaining applicants of advanced age?
"The minimum age for participation in this trial is 18, with a maximum of 70. However, there are 303 trials that cater to minors and 674 specifically designed for seniors."
Is enrollment for this investigation still open?
"Affirmative. Clinicaltrials.gov states that this clinical trial, which was initially posted on June 5th 2020 and most recently updated on September 21st 2021, is actively seeking participants. Approximately 300 candidates are required to be recruited from a single location."
What is the participant enrollment size for this research endeavor?
"Affirmative, the information provided by clinicaltrials.gov confirms that this study is still searching for participants. The trial was initially published on June 5th 2020 and updated recently on September 21st 2021 with a goal of recruiting 300 patients from 1 healthcare site."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger